Raised plasma aldosterone and natriuretic peptides in atrial fibrillation

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Standard

Raised plasma aldosterone and natriuretic peptides in atrial fibrillation. / Dixen, U; Ravn, L; Soeby-Rasmussen, C; Paulsen, AW; Parner, J; Frandsen, E; Jensen, Gorm B; Dixen, Ulrik; Ravn, Lasse Steen; Soeby-Rasmussen, Christian; Paulsen, Anders Wallin; Parner, Jan; Frandsen, Erik.

I: Cardiology, Bind 108, Nr. 1, 2007, s. 35-9.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Harvard

Dixen, U, Ravn, L, Soeby-Rasmussen, C, Paulsen, AW, Parner, J, Frandsen, E, Jensen, GB, Dixen, U, Ravn, LS, Soeby-Rasmussen, C, Paulsen, AW, Parner, J & Frandsen, E 2007, 'Raised plasma aldosterone and natriuretic peptides in atrial fibrillation', Cardiology, bind 108, nr. 1, s. 35-9. https://doi.org/10.1159/000095671

APA

Dixen, U., Ravn, L., Soeby-Rasmussen, C., Paulsen, AW., Parner, J., Frandsen, E., Jensen, G. B., Dixen, U., Ravn, L. S., Soeby-Rasmussen, C., Paulsen, A. W., Parner, J., & Frandsen, E. (2007). Raised plasma aldosterone and natriuretic peptides in atrial fibrillation. Cardiology, 108(1), 35-9. https://doi.org/10.1159/000095671

Vancouver

Dixen U, Ravn L, Soeby-Rasmussen C, Paulsen AW, Parner J, Frandsen E o.a. Raised plasma aldosterone and natriuretic peptides in atrial fibrillation. Cardiology. 2007;108(1):35-9. https://doi.org/10.1159/000095671

Author

Dixen, U ; Ravn, L ; Soeby-Rasmussen, C ; Paulsen, AW ; Parner, J ; Frandsen, E ; Jensen, Gorm B ; Dixen, Ulrik ; Ravn, Lasse Steen ; Soeby-Rasmussen, Christian ; Paulsen, Anders Wallin ; Parner, Jan ; Frandsen, Erik. / Raised plasma aldosterone and natriuretic peptides in atrial fibrillation. I: Cardiology. 2007 ; Bind 108, Nr. 1. s. 35-9.

Bibtex

@article{b155f0a0cfa5492290a4b7f1da80d166,
title = "Raised plasma aldosterone and natriuretic peptides in atrial fibrillation",
abstract = "During atrial fibrillation (AF), the renin-angiotensin-aldosterone system (RAAS) may be activated. In this study, our aim was to evaluate at a long-term follow-up visit the levels of plasma aldosterone and natriuretic peptides as markers of neurohormonal remodeling in patients with earlier, documented AF in relation to present heart rhythm, clinical data, and the left ventricular ejection fraction (LVEF). We hypothesized that increased levels of aldosterone and natriuretic peptides were significantly associated with present AF as markers of RAAS activation during the arrhythmia.",
author = "U Dixen and L Ravn and C Soeby-Rasmussen and AW Paulsen and J Parner and E Frandsen and Jensen, {Gorm B} and Ulrik Dixen and Ravn, {Lasse Steen} and Christian Soeby-Rasmussen and Paulsen, {Anders Wallin} and Jan Parner and Erik Frandsen",
note = "Copyright 2007 S. Karger AG, Basel.",
year = "2007",
doi = "http://dx.doi.org/10.1159/000095671",
language = "English",
volume = "108",
pages = "35--9",
journal = "Cardiologia",
issn = "0008-6312",
publisher = "S Karger AG",
number = "1",

}

RIS

TY - JOUR

T1 - Raised plasma aldosterone and natriuretic peptides in atrial fibrillation

AU - Dixen, U

AU - Ravn, L

AU - Soeby-Rasmussen, C

AU - Paulsen, AW

AU - Parner, J

AU - Frandsen, E

AU - Jensen, Gorm B

AU - Dixen, Ulrik

AU - Ravn, Lasse Steen

AU - Soeby-Rasmussen, Christian

AU - Paulsen, Anders Wallin

AU - Parner, Jan

AU - Frandsen, Erik

N1 - Copyright 2007 S. Karger AG, Basel.

PY - 2007

Y1 - 2007

N2 - During atrial fibrillation (AF), the renin-angiotensin-aldosterone system (RAAS) may be activated. In this study, our aim was to evaluate at a long-term follow-up visit the levels of plasma aldosterone and natriuretic peptides as markers of neurohormonal remodeling in patients with earlier, documented AF in relation to present heart rhythm, clinical data, and the left ventricular ejection fraction (LVEF). We hypothesized that increased levels of aldosterone and natriuretic peptides were significantly associated with present AF as markers of RAAS activation during the arrhythmia.

AB - During atrial fibrillation (AF), the renin-angiotensin-aldosterone system (RAAS) may be activated. In this study, our aim was to evaluate at a long-term follow-up visit the levels of plasma aldosterone and natriuretic peptides as markers of neurohormonal remodeling in patients with earlier, documented AF in relation to present heart rhythm, clinical data, and the left ventricular ejection fraction (LVEF). We hypothesized that increased levels of aldosterone and natriuretic peptides were significantly associated with present AF as markers of RAAS activation during the arrhythmia.

U2 - http://dx.doi.org/10.1159/000095671

DO - http://dx.doi.org/10.1159/000095671

M3 - Journal article

VL - 108

SP - 35

EP - 39

JO - Cardiologia

JF - Cardiologia

SN - 0008-6312

IS - 1

ER -

ID: 34141956